Results 211 to 220 of about 25,697 (255)
Some of the next articles are maybe not open access.

Problem pharmaceutical patents

World Patent Information, 1996
Abstract These days, the number of pharmaceutical patent applications which do not specify the principal active ingredient in the form of a chemical name or structure is increasing. These patents are difficult to retrieve in retrospective on-line searches using chemical structures or keywords.
Masaharu Kubo, Yukinori Itoh
openaire   +1 more source

Pharmaceutical patents and price controls

Clinical Therapeutics, 2002
Since 1995, every member-country of the World Trade Organization (WTO) has agreed to honor a 20-year patent-life, from the date of a pharmaceutical company's application for the patent, in the country of application. Patent protection retards competitive imitation of an invented product.
openaire   +2 more sources

Gene Patents—A Pharmaceutical Perspective

Cambridge Quarterly of Healthcare Ethics, 1998
The decade-long debate over ownership of living human materials has recently intensified with the ability of biomedical research to isolate, purify, and use human genes and gene products as therapeutics, factories for the production of therapeutics, and targets for the identification of therapeutic pharmaceuticals.
openaire   +2 more sources

Pharmaceutical Patents and Healthcare

Socio-Legal Review, 2006
An essay on how the post-T.R.I.P.S.
openaire   +1 more source

Patents and Pharmaceuticals

Abstract This chapter focuses on the use of patents in the pharmaceutical sector. It begins by describing the basic characteristics of the industry, and the R&D and drug development process in that industry. It then reviews the role of the patent system in the industry, its effects on drug availability and pricing, and the ...
Bronwyn H. Hall, Christian Helmers
openaire   +1 more source

Patent citation analysis of Allergan pharmaceutical patents

Expert Opinion on Therapeutic Patents, 1998
This is the second in a series of articles that apply patent citation analysis techniques to pharmaceutical patents. Co-citation clustering was used to identify the core pharmaceutical technological competencies of Allergan, Inc. and the technology fronts that this company is advancing.
Mary Ellen Mogee, Richard G Kolar
openaire   +1 more source

Pharmaceutical Patent Law: the Canadian Perspective

Pharmaceutical Patent Analyst, 2016
This article provides an overview of the patent regime in Canada, with a focus on issues most relevant to the pharmaceutical industry. The process of applying for a patent is discussed, as well as enforcement and litigation. Recent developments in the case law dealing with patentability requirements - novelty, obviousness, utility and sufficiency - are
Livia, Aumand, John, Norman
openaire   +2 more sources

Patents and trademarks in pharmaceuticals

World Development, 1983
Abstract While the role of patents and trademarks in reinforcing the market power of TNCs operating in the pharmaceutical industry is beyond doubt, the possibilities of reducing such market power through public policies dealing with industrial property in developing countries are less clear.
openaire   +1 more source

Law on Pharmaceutical Patents

SSRN Electronic Journal, 2012
India is known as the global pharmaceutical capital because of the ever growing generic drug manufacturing industry. With the growth of such an industry the issue of protection to pharmaceutical patents is also gaining importance. Pharmaceutical patent protection is of prime importance to pharma companies because of the huge amount of money invested in
openaire   +1 more source

Pharmaceutical Patent Applications in freeze-drying

Pharmaceutical Patent Analyst, 2016
Injectable products are often the formulation of choice for new therapeutics; however, formulation in liquids often enhances degradation through hydrolysis. Thus, freeze-drying (lyophilization) is regularly used in pharmaceutical manufacture to reduce water activity.
Edmond, Ekenlebie   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy